Literature DB >> 28799566

shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells.

P Chen1, W-L Gu1, M-Z Gong1, J Wang1, D-Q Li2.   

Abstract

In this study, we aim to explore the effects of short hairpin RNAs (shRNAs) targeting human telomerase reverse transcriptase (hTERT) on the proliferation and apoptosis of osteosarcoma cells. After the synthesis of shRNA that target hTERT, osteosarcoma cells were assigned into three experimental groups-shRNA group, scramble group and blank group. The transcription and expressions of the hTERT gene in transfected cells were measured with quantitative real-time polymerase chain reaction and western blotting. Cell proliferation in each group was detected by Cell Counting Kit-8 assay. Cell cycle and rates of apoptosis were measured by flow cytometry. Expressions of apoptosis-related proteins, caspase-9 and caspase-3, were detected by western blotting. Telomerase activity was measured by PCR enzyme-linked immunosorbent assay. Results show that both the mRNA and protein expressions of hTERT were significantly lowered after the transfection of hTERT-shRNA. The proliferation capacity of transfected osteosarcoma MG-63, SaOS2 and U2OS cells in the shRNA group was lower than that in the blank group. We also found changes and differences in the amount of cells throughout the cell cycle. All cells in the G0/G1 phase increased in numbers, whereas the number of cells in the S phase were reduced, with elevated apoptosis rates. Expressions of apoptosis-related proteins, caspase-9 and caspase-3, were increased and telomerase activity was decreased in the transfected shRNA group (all P<0.05). Our results showed that shRNA targeting of the hTERT gene was able to inhibit cell proliferation and promote apoptosis of osteosarcoma cells by reducing the telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28799566     DOI: 10.1038/cgt.2017.22

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  25 in total

Review 1.  Small RNA molecules in the regulation of spermatogenesis.

Authors:  Zuping He; Maria Kokkinaki; Disha Pant; G Ian Gallicano; Martin Dym
Journal:  Reproduction       Date:  2009-03-24       Impact factor: 3.906

2.  Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro.

Authors:  Haibo Tang; Linhu Ge; Wenlong Shao; Yuan Qiu; Dong Cui
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

Review 3.  Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.

Authors:  Dong Yao; Guo-Hong Cai; Jing Chen; Rui Ling; Sheng-Xi Wu; Yong-Ping Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

Authors:  Victoria L Bae-Jump; Chunxiao Zhou; Paola A Gehrig; Young E Whang; John F Boggess
Journal:  Gynecol Oncol       Date:  2005-10-24       Impact factor: 5.482

5.  Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.

Authors:  Z Liu; Q Li; K Li; L Chen; W Li; M Hou; T Liu; J Yang; C Lindvall; M Björkholm; J Jia; D Xu
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

Review 6.  Senescence and immortalization: role of telomeres and telomerase.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Carcinogenesis       Date:  2004-10-07       Impact factor: 4.944

7.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity.

Authors:  Ling Yu; Shiqing Liu; Chun Zhang; Bo Zhang; Bruno M Simões; Rachel Eyre; Yi Liang; Huichao Yan; Zheng Wu; Weichun Guo; Robert B Clarke
Journal:  Oncotarget       Date:  2013-12

9.  Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.

Authors:  Brock J Sishc; Christopher B Nelson; Miles J McKenna; Christine L R Battaglia; Andrea Herndon; Rupa Idate; Howard L Liber; Susan M Bailey
Journal:  Front Oncol       Date:  2015-11-24       Impact factor: 6.244

Review 10.  Crosstalk between Autophagy and Apoptosis: Potential and Emerging Therapeutic Targets for Cardiac Diseases.

Authors:  Meng Li; Ping Gao; Junping Zhang
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

View more
  6 in total

Review 1.  Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.

Authors:  Chiara Rinoldi; Seyed Shahrooz Zargarian; Pawel Nakielski; Xiaoran Li; Anna Liguori; Francesca Petronella; Dario Presutti; Qiusheng Wang; Marco Costantini; Luciano De Sio; Chiara Gualandi; Bin Ding; Filippo Pierini
Journal:  Small Methods       Date:  2021-07-28

2.  Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma.

Authors:  Abdulraheem Gul Mohammad; Dapeng Li; Rong He; Xuan Lei; Lianghao Mao; Bing Zhang; Xinyu Zhong; Zhengyu Yin; Wenbing Cao; Wenchao Zhang; Ruoxuan Hei; Qiping Zheng; Yiming Zhang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.

Authors:  Valentina Maggisano; Marilena Celano; Saverio Massimo Lepore; Marialuisa Sponziello; Francesca Rosignolo; Valeria Pecce; Antonella Verrienti; Federica Baldan; Catia Mio; Lorenzo Allegri; Marianna Maranghi; Rosa Falcone; Giuseppe Damante; Diego Russo; Stefania Bulotta
Journal:  Endocrine       Date:  2019-01-19       Impact factor: 3.633

4.  Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R.

Authors:  Kaihua Chen; Ling Li; Song Qu; Xinbin Pan; Yongchu Sun; Fangzhu Wan; Binbin Yu; Lei Zhou; Xiaodong Zhu
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

5.  Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro.

Authors:  Chengle Zhuang; Changshui Zhuang; Qun Zhou; Xueting Huang; Yaoting Gui; Yongqing Lai; Shangqi Yang
Journal:  Front Mol Biosci       Date:  2021-03-19

6.  TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis.

Authors:  Yanbing Wang; Yiwu Chen; Chang Li; Zhiwei Xiao; Hongming Yuan; Yuanzhu Zhang; Daxin Pang; Xiaochun Tang; Mengjing Li; Hongsheng Ouyang
Journal:  Biology (Basel)       Date:  2022-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.